KGI Research Singapore

Singapore's leading broker offering Futures, FX, Equities and Wealth Management.

9 Dec 2021: Stocks making the biggest moves

Market Movers | Trading Dashboard

Market Movers

United States

Top Sector Gainers

SectorGainRelated News
Technology Hardware & Equipment1.6%Chip fabs are coming to the U.S., but will there be enough skilled workers?
Automobiles & Components1.22%53 US utilities will build a nationwide fast-charging EV network by end of 2023
Consumer Services1.16%Visa launches crypto consulting services in push for mainstream adoption

Top Sector Losers

SectorLossRelated News
Food & Staples Retailing-1.54%NA
Banks-1.1%Volatility Strikes Bank Stocks, but Optimism Remains
Semiconductors & Semiconductor Equipment-0.87%Crypto executives urge light touch as Congress mulls new regulation

  • Docusign Inc (DOCU US). Shares jumped 10.9% yesterday. Two days ago, famed tech investor Cathie Wood stepped up to snap up DocuSign shares amid the sell-off, helping to salvage the stock. On Monday, CEO Dan Springer bought 33,675 DocuSign shares for a combined US$4.8mn, at prices ranging from US$139.93 to US$146.91 a share. One week ago, DocuSign suffered a one-day 42% plunge after the company posted financial results for its fiscal third quarter, ended Oct. 31, that showed AN unexpected slowing of the business, as the boost provided by the pandemic showed signs of fading.
  • Norwegian Cruise Line Holdings Ltd (NCLH US), Royal Caribbean Cruises Ltd (RCL US), Expedia Group Inc (EXPE US). Travel sector shares jumped yesterday. Shares gained 8.2%, 5.2% and 3.5% respectively yesterday, after Pfizer and BioNTech announced that the Covid-19 vaccine neutralises Omicron with 3 shots. The companies said that two doses of their vaccine resulted in significantly lower neutralising antibodies but could still be protective against severe disease. There is no significant data yet on how vaccines from Moderna, Johnson & Johnson and other drugmakers hold up against the new variant but they are expected to release their own data within weeks.
  • Apple Inc (AAPL US). Shares rose 2.3% yesterday, reaching an all-time high and is within striking distance to hit a US$1tr market cap. Morgan Stanley has raised its Apple price target to US$200, driven by what is expected from the company relatively soon, as well as short-term drivers like the App Store and iPhone supply. In addition, last month, Apple announced that it is accelerating efforts to launch a self-driving vehicle and is pushing internally for a 2025 deadline for an autonomous vehicle.


  • Yangzijiang Shipbuilding (YZJSGD SP) shares closed 1.5% lower yesterday after the company said that it plans to spin off its investment segment in a listing on the SGX mainboard. Upon successful completion of the proposed spin-off and listing, it is proposed that shareholders of the Company will receive shares of the Spin-off Group proportionally in the form of dividend in specie.
  • Singtel (ST SP) shares gained 1.2% yesterday after it was announced that its Australian subsidiary Optus has acquired spectrum licences in the 900 megahertz (MHz) spectrum band in Australia to boost its 5G coverage, for a total of A$1.48 billion. The licences for the 2 25 MHz across Australia will help deliver “a significant uplift in 5G coverage nation-wide.” Chief Executive Kelly Bayer Rosmarin said the 900 MHz spectrum is the company’s foundational layer in its network.
  • AusGroup (AUSG SP) shares lost 4% yesterday, likely on profit taking. The company previously announced that it has secured a contract for the construction of a lithium refinery for Covalent Lithium, a joint venture between Australian-listed Wesfarmers and New York Stock Exchange-listed Sociedad Quimica y Minera de Chile. AusGroup will supply, fabricate and deliver 58 stainless steel and carbon steel tanks for the refinery.
  • First Resources (FR SP) shares gained 1.3% yesterday. DBS Group Research upgraded the stock to “Buy” from “Hold” with an unchanged target price of $1.83, following a correction in the share price by 20% in November, presenting a good buying opportunity. DBS maintained its forecast that earnings will expand 8.6 per cent year on year to US$146 million in FY2022, despite assuming higher CPO selling prices.
  • Olam International (OLAM SP) shares jumped 3.5% after it was announced that the company has secured a US$150 million club loan referencing the USD Secured Overnight Financing Rate (SOFR) with DBS and ICBC. The proceeds will allow for the carve-out, separation and proposed demerger and initial public offering of its new operating group Olam Food Ingredients (Ofi), which looks into natural and sustainable food ingredients and solutions.

Hong Kong

Top Sector Gainers

SectorGainRelated News
Food Additives & Flavouring3.03%NA
Airlne Support2.92%China’s HNA transfers airline management to Fangda Group
Electricity Supply2.67%NA

Top Sector Losers

SectorLossRelated News
Diversified Food & Beverage-2.3%NA
Road and Railway-1.32%Chinese cities rush to provide trains to China-Laos rail ahead of RCEP, a boon to SE Asia economy
Precious Metal-1.04%Gold stalls as investors look for direction from Fed, inflation data

  • China Power International Dev Ltd (2380 HK), Huaneng Power International Inc (902 HK), CGN New Energy Holdings Co Ltd (1811 HK). Power sector shares rose collectively yesterday. Shares rose 11.4%, 7.9% and 6.5% respectively. The Guangdong Provincial Development and Reform Commission approved the implementation of a plan where agency power purchase price includes three parts: average on-grid power price, auxiliary service fee and new profit and loss sharing caused by stable agricultural power prices. The related costs are shared by all industrial and commercial users who directly participate in market transactions and power grid companies purchase electricity as agents.
  • Zai Lab Ltd (9688 HK). Shares rose 10.2% yesterday. The company announced that its subsidiary has been included in the latest National Medical Insurance Drug List released by the National Medical Security Administration of China for advanced epithelial ovarian cancer, fallopian tube cancer or primary peritoneal cancer (collectively referred to as ovarian cancer). It is the first-line maintenance treatment for adult patients who respond to platinum-containing chemotherapy.
  • Genscript Biotech Corp (1548 HK). Shares rose 8.4% yesterday. The company announced that its non-wholly-owned subsidiary Legend Biotechnology Co Ltd announced that its partner Janssen Pharmaceutical Co Ltd submitted the cilta-cel certificate to the Ministry of Health, Labour and Welfare of Japan. Cilta-cel is an ongoing research targeting B cell maturation antigen chimeric antigen receptor T cell therapy for the treatment of adult patients with relapsed or refractory multiple myeloma.
  • Trading Dashboard: Cut (9961 HK) at HK$205.

^ Back To Top

Trading Dashboard

(Click to enlarge image)

^ Back To Top

Subscribe Now

Related Posts:

Leave a Reply

Your email address will not be published. Required fields are marked *